Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pellagatti

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Advances in Biological Regulation|September 19, 2016
Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applicationsAndrea Pellagatti, Jacqueline Boultwood
Nature Medicine|July 8, 2014
Reduced translation of GATA1 in Diamond-Blackfan anemiaJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|September 28, 2019
Splicing factor mutant myelodysplastic syndromes: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Blood|September 24, 2020
Spliceosome mutations: 1 plus 1 does not always equal 2Andrea Pellagatti, Jacqueline Boultwood
Mediterranean Journal of Hematology and Infectious Diseases|June 16, 2015
Recent Advances in the 5q- SyndromeAndrea Pellagatti, Jacqueline Boultwood
The Lancet. Haematology|December 22, 2015
Clinical associations of CSNK1A1 mutation in myelodysplastic syndromeJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|December 28, 2020
SF3B1 mutant myelodysplastic syndrome: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation|October 10, 2022
Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatmentAndrea Pellagatti, Jacqueline Boultwood
Hemasphere|March 21, 2022
The impact of spliceosome mutations in MDSJacqueline Boultwood, Andrea Pellagatti
European Journal of Haematology|February 4, 2015
The molecular pathogenesis of the myelodysplastic syndromesAndrea Pellagatti, Jacqueline Boultwood
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Advances in Biological Regulation|September 19, 2016
Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applicationsAndrea Pellagatti, Jacqueline Boultwood
Nature Medicine|July 8, 2014
Reduced translation of GATA1 in Diamond-Blackfan anemiaJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|September 28, 2019
Splicing factor mutant myelodysplastic syndromes: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Blood|September 24, 2020
Spliceosome mutations: 1 plus 1 does not always equal 2Andrea Pellagatti, Jacqueline Boultwood
Mediterranean Journal of Hematology and Infectious Diseases|June 16, 2015
Recent Advances in the 5q- SyndromeAndrea Pellagatti, Jacqueline Boultwood
The Lancet. Haematology|December 22, 2015
Clinical associations of CSNK1A1 mutation in myelodysplastic syndromeJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|December 28, 2020
SF3B1 mutant myelodysplastic syndrome: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation|October 10, 2022
Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatmentAndrea Pellagatti, Jacqueline Boultwood
Hemasphere|March 21, 2022
The impact of spliceosome mutations in MDSJacqueline Boultwood, Andrea Pellagatti
European Journal of Haematology|February 4, 2015
The molecular pathogenesis of the myelodysplastic syndromesAndrea Pellagatti, Jacqueline Boultwood
Pageof 11